Logo image
Recruitment and results of a pilot trial of vitamin D supplementation in the general population of Australia
Journal article   Open access   Peer reviewed

Recruitment and results of a pilot trial of vitamin D supplementation in the general population of Australia

B Tran, B K Armstrong, J B Carlin, P R Ebeling, D R English, Michael G Kimlin, B Rahman, J C Van Der Pols, A Venn, V Gebski, …
Journal of Clinical Endocrinology and Metabolism, Vol.97(12), pp.4473-4480
2012
pdf
PDF - Published Version297.72 kBDownloadView
Published VersionPDF - Published Version Open Access
url
https://doi.org/10.1210/jc.2012-2682View
Published Version

Abstract

vitamin D pilot trial
Context: The benefits of high serum levels of 25-hydroxyvitamin D [25(OH)D] are unclear. Trials are needed to establish an appropriate evidence base. Objective: We plan to conduct a large-scale trial of vitamin D supplementation for the reduction of cancer incidence and overall mortality and report here the methods and results of a pilot trial established to inform its design. Design: Pilot D-Health was a randomized trial carried out in a general community setting with 12 months intervention and follow-up. Participants: Participants were 60- to 84-yr-old residents of one of the four eastern Australian states who did not have any vitamin D-related disorders and who were not taking more than 400 IU supplementary vitamin D per day. A total of 644 participants were randomized, and 615 completed the study (two persons withdrew because of nonserious adverse events). Interventions: The interventions were monthly doses of placebo or 30,000 or 60,000 IU vitamin D3. Main Outcomes: The main outcomes were the recruitment rate and changes in serum 25(OH)D. Results: Ten percent of those approached were recruited. At baseline, the mean 25(OH)D was 42 nmol/liter in all three study arms. The mean change in 25(OH)D in the placebo group was 0.12 nmol/liter, compared with changes of 22 and 36 nmol/liter in the 30,000- and 60,000-IU groups, respectively. Conclusions: The D-Health pilot has shown that a large trial is feasible in Australia and that a dose of 2000 IU/d will be needed to ensure that a large proportion of the population reaches the target serum 25(OH)D level. Copyright © 2012 by The Endocrine Society.

Details

Metrics

88 File views/ downloads
677 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Web Of Science research areas
Endocrinology & Metabolism

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image